SCHEMBL7769242

SCHEMBL7769242

Cc1cnc(N2CCN(C(N)Cc3nc4ccc(F)cc4s3)CC2)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGA O60502 6/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 2/20 0.40
TP53 P04637 2/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 2/20 0.38
GFER P55789 2/20 0.37
AXL P30530 1/20 0.37
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
DHFR P00374 1/20 0.35
TRPV1 Q8NER1 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
PKM P14618 1/20 0.35
ALOX12 P18054 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7775356 0.99 OGA (0.41) OGANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7856234 0.93 OGA (0.43) OGANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7775417 0.89 DRD2 (0.45) OGANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7773495 0.85 DRD2 (0.48) OGANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7775460 0.83 NPC1 (0.48) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
Bromide SCHEMBL7857772 0.82 NPC1 (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
SCHEMBL7773399 0.81 DRD2 (0.48) OGANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL27565727 0.81 NPC1 (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
Fumaric Acid SCHEMBL7775355 0.81 KDM4E (0.42) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
Bromide SCHEMBL27545758 0.80 NPC1 (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO claimed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO claimed
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN disclosed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed